Infectious Disease Diagnostics Testing Market Growth Outlook: Key Drivers and Emerging Opportunities (2025-2034)

How big is the infectious disease diagnostics testing market today, and what are its future growth expectations?

The infectious disease diagnostics testing market size has grown rapidly in recent years. It will grow from $38.52 billion in 2024 to $42.56 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to rising disease outbreaks such as SARS, Ebola, and Zika, growing awareness among healthcare professionals and the general public about the importance of early detection and prevention of infectious diseases, rise in government-funded programs for disease surveillance, control, and prevention, increasing global travel and trade have facilitated the spread of infectious diseases, and increased healthcare spending, particularly in emerging economies.

The infectious disease diagnostics testing market size is expected to see rapid growth in the next few years. It will grow to $62.58 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to the continuous emergence of novel pathogens, such as new strains of influenza or COVID-19es, the shift towards personalized medicine and targeted therapies, increasing demand for rapid and on-site testing solutions, Growing emphasis on epidemiological surveillance and early detection systems, and increased research and developments activities focused on developing novel diagnostic technologies and biomarkers. Major trends in the forecast period include miniaturization and portability of diagnostic devices, adoption of multiplex assays capable of detecting multiple pathogens simultaneously, integration of digital health solutions, such as mobile apps and telemedicine platforms, adoption of next-generation sequencing (NGS) technologies in infectious disease diagnostics, advancements in biosensor technologies for rapid and sensitive detection of infectious agents, and integration of AI and machine learning algorithms into diagnostic platforms.

Get Your Free Sample of The Global Infectious Disease Diagnostics Testing Market Report:
Infectious Disease Diagnostics Testing Market Report 2025, Analysis And Forecast Sample

How has the infectious disease diagnostics testing market evolved, and what factors have shaped its growth?

A rise in respiratory infections is expected to propel the growth of the infectious disease diagnostic testing market going forward. Respiratory infections affect the respiratory system, including the nose, throat, airways, and lungs. The increasing respiratory infections are due to viral and bacterial transmission through close contact with infected individuals, poor hygiene practices, crowded living conditions, and seasonal variations in weather patterns. Infectious disease diagnostic testing is essential for diagnosing and treating respiratory infections as it can precisely identify pathogens such as bacteria and viruses in patient samples. For instance, in February 2024, according to the Canadian Institute for Health Information, a Canada-based non-profit organization, hospitalizations for acute upper respiratory infections increased by 32% from 2,114 in 2022 to 2,797 cases in 2023. Therefore, the rise in respiratory infections is driving the infectious disease diagnostic testing market.

What are the major segments of the infectious disease diagnostics testing market?
The infectious disease diagnostics testing market covered in this report is segmented –

1) By Type: Molecular Diagnostic Test, Point Of Care Tests (POCT) Infectious Disease Diagnostics Test
2) By Application: Respiratory, Human Immunodeficiency Virus (HIV), Healthcare-Associated Infections (HAIs), Sexual Health, Tropical Diseases, Liver
3) By End-User: Diagnostic Laboratories, Hospitals And Clinics, Academic Research Institutes, Other End-Users

Subsegments:
1) By Molecular Diagnostic Test: Polymerase Chain Reaction (PCR) Tests, Nucleic Acid Amplification Tests (NAATs), Next-Generation Sequencing (NGS), Microarray-Based Tests
2) By Point Of Care Tests (POCT) Infectious Disease Diagnostics Test: Lateral Flow Assays, Rapid Antigen Tests, Immunoassays, Portable PCR

Order your report now for swift delivery
Infectious Disease Diagnostics Testing Market Report 2025, Analysis And Forecast

Which companies dominate the infectious disease diagnostics testing market?

Major companies operating in the infectious disease diagnostics testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMérieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin SpA (Luminex), Myriad Genetics Inc., Seegene Inc., Ortho Clinical Diagnostics Inc., OraSure Technologies Inc., Meridian Bioscience Inc., Trinity Biotech PLC, Biodesix Inc., Helix OpCo LLC, Inovio Pharmaceuticals Inc.

How will evolving trends contribute to the growth of the infectious disease diagnostics testing market?

Major companies operating in the infectious disease diagnostic testing market are focusing on developing innovative technologies, such as molecular diagnostics platforms, to sustain their position in the market. Molecular diagnostics platforms are sophisticated systems designed to detect and analyze nucleic acids (DNA or RNA) from biological samples for diagnostic purposes. For instance, in May 2022, Becton Dickinson, and Company, a US-based medical technology company, launched BD COR System, a fully automated, high-throughput infectious disease molecular diagnostics platform. This platform integrates and automates the complete molecular laboratory workflow from sample processing to diagnostic results, eliminating the need for manual specimen sorting and freeing up lab technicians for higher-value tasks. The system can process up to 1,700 specimens and deliver results within 24 hours, offering high-throughput capabilities and advanced genotyping for diseases such as HPV and STIs.

What are the key regional dynamics of the infectious disease diagnostics testing market, and which region leads in market share?

North America was the largest region in the infectious disease diagnostics testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease diagnostics testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Does The Infectious Disease Diagnostics Testing Market Report 2025 Offer?

The infectious disease diagnostics testing market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.

Infectious disease diagnostics testing refers to the process of identifying the presence of pathogens, such as bacteria, viruses, fungi, or parasites, in a patient’s body. These tests are crucial for diagnosing infectious diseases and guiding appropriate treatment decisions. Infectious disease diagnostics testing plays a vital role in controlling the spread of infectious diseases, guiding treatment decisions, and monitoring outbreaks.

Purchase the exclusive report now to unlock valuable market insights:
Infectious Disease Diagnostics Testing Market Report 2025, Analysis And Forecast

About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.

Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: The Business Research Company (@tbrc_info) on X
Facebook: The Business Research Company | London
YouTube: The Business Research Company
Blog: Specialty Tapes Market Insights 2025-2034: Growth Dynamics, Trends, and Strategic Opportunities – Latest Global Market Insights
Healthcare Blog: Latest Healthcare Research Reports – By The Business Research Company
Global Market Model: Global Market Intelligence Database

Leave a Reply

Your email address will not be published. Required fields are marked *